Atrys Health Sl Stock Fundamentals
| ATRY Stock | EUR 3.23 0.04 1.22% |
Atrys Health SL fundamentals help investors to digest information that contributes to Atrys Health's financial success or failures. It also enables traders to predict the movement of Atrys Stock. The fundamental analysis module provides a way to measure Atrys Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atrys Health stock.
Atrys |
Atrys Health SL Company Current Valuation Analysis
Atrys Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Atrys Health Current Valuation | 647.57 M |
Most of Atrys Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atrys Health SL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Atrys Health SL has a Current Valuation of 647.57 M. This is 95.49% lower than that of the Healthcare sector and 86.06% lower than that of the Biotechnology industry. The current valuation for all Spain stocks is 96.1% higher than that of the company.
Atrys Health SL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Atrys Health's current stock value. Our valuation model uses many indicators to compare Atrys Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atrys Health competition to find correlations between indicators driving Atrys Health's intrinsic value. More Info.Atrys Health SL is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Atrys Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atrys Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Atrys Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atrys Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atrys Health could also be used in its relative valuation, which is a method of valuing Atrys Health by comparing valuation metrics of similar companies.Atrys Health is rated second in current valuation category among its peers.
Atrys Fundamentals
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 647.57 M | |||
| Shares Outstanding | 75.89 M | |||
| Shares Owned By Insiders | 78.47 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 2.47 X | |||
| Revenue | 121.01 M | |||
| Gross Profit | 27.78 M | |||
| EBITDA | 6.88 M | |||
| Net Income | (23.25 M) | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 146.81 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 4.67 X | |||
| Cash Flow From Operations | 4.69 M | |||
| Earnings Per Share | (0.46) X | |||
| Target Price | 10.46 | |||
| Number Of Employees | 2.4 K | |||
| Beta | 0.37 | |||
| Market Capitalization | 461.42 M | |||
| Total Asset | 565.63 M | |||
| Z Score | 1.8 | |||
| Net Asset | 565.63 M |
About Atrys Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atrys Health SL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atrys Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atrys Health SL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.